Cargando…
Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer
BACKGROUND: Loss of BIN1 tumor suppressor expression is abundant in human cancer and its frequency exceeds that of genetic alterations, suggesting the role of epigenetic regulators (DNA methylation). BIN1 re-expression in the DU145 prostate cancer cell line after 5-aza-2'-deoxycytidine treatmen...
Autores principales: | Kuznetsova, Ekaterina B, Kekeeva, Tatiana V, Larin, Sergei S, Zemlyakova, Valeria V, Khomyakova, Anastasiya V, Babenko, Olga V, Nemtsova, Marina V, Zaletayev, Dmitry V, Strelnikov, Vladimir V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876449/ https://www.ncbi.nlm.nih.gov/pubmed/17477881 http://dx.doi.org/10.1186/1477-3163-6-9 |
Ejemplares similares
-
Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and its Relation to Epigenomic Subtypes and HER2 Overexpression
por: Simonova, Olga A., et al.
Publicado: (2020) -
Methylation profiling of carcinogenesis-associated genes in sporadic breast cancer
por: Nemtsova, M, et al.
Publicado: (2005) -
Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer
por: Strelnikov, Vladimir V., et al.
Publicado: (2021) -
Intergenic, gene terminal, and intragenic CpG islands in the human genome
por: Medvedeva, Yulia A, et al.
Publicado: (2010) -
Genomic landscape of CpG rich elements in human
por: Babenko, Vladimir N., et al.
Publicado: (2017)